Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women

Wassertheil‐Smoller, Sylvia; L. Hendrix, Susan; C. Limacher, Marian; Heiss, Gerardo; Kooperberg, Charles; E. Baird, Alison; A. Kotchen, Theodore; David Curb, J.; R. Black, Henry; E. Rossouw, Jacques; K. Aragaki, Aaron; Safford, Monika; A. Stein, Evan; Laowattana, Somchai; Jerry Mysiw, W.; the WHI Investigators, for

doi:10.1001/jama.289.20.2673

Public

Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women

Published in JAMA • May 27, 2003

Authors:

Sylvia Wassertheil‐Smoller

Susan L. Hendrix

Marian C. Limacher

Abstract

CONTEXT: The Women's Health Initiative (WHI) trial of estrogen plus progestin was stopped early because of adverse effects, including an increased risk of stroke in the estrogen plus progestin group. OBJECTIVE: To assess the effect of estrogen plus progestin on ischemic and hemorrhagic stroke and in...

Subject

Medicine

Medroxyprogesterone acetate

Estrogen

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!